Eli Lilly CFO converts stock awards to 1,610 shares

Eli Lilly's EVP & CFO had a reported position of 0 restricted stock units after conversion; 678 shares were also delivered or withheld for payment.

Available on EDGAR 11/03/2026 - 04:14 PM EST Accepted by SEC EDGAR 11/03/2026 - 04:14 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Eli Lilly EVP & CFO Lucas Montarce converted 1,610 restricted stock units into 1,610 common shares on November 1, 2026. Each unit represents a contingent right to receive one common share, and the reported restricted-stock-unit position was 0 after conversion. On the same date, 678 common shares were delivered or withheld for payment of exercise price or tax liability, at a reported price of $1,417.54 per share.

Insider Trade Summary

1,610 shares exercised/converted

Exercise 3 txns

Insider Montarce Lucas

Role EVP & CFO

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit F1	1,610	$0.00	$0.00
Exercise	Common Stock	1,610	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	677.593	$1,417.54	$961K

Holdings After Transaction: Restricted Stock Unit — 0 contracts (Direct); Common Stock — 17,190.88 shares (Direct)

Holdings Before and After: Restricted Stock Unit, 1,610 to 0 contracts (Direct); Common Stock, 16,258.473 to 17,190.88 shares (Direct)

Footnotes (1)

1. F1. Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

Key Figures

Restricted stock units converted: 1,610 restricted stock units Common shares received: 1,610 shares Shares delivered or withheld: 678 shares +2 more

5 metrics

Restricted stock units converted 1,610 restricted stock units November 1, 2026

Common shares received 1,610 shares On conversion of the restricted stock units

Shares delivered or withheld 678 shares For payment of exercise price or tax liability on November 1, 2026

Reported price per share $1,417.54 per share Shares delivered or withheld on November 1, 2026

Restricted stock units after conversion 0 restricted stock units Following the November 1, 2026 transaction

Key Terms

restricted stock unit, contingent right, tax liability

3 terms

restricted stock unit financial

"Each restricted stock unit represents a contingent right"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

contingent right financial

"represents a contingent right to receive one share"

tax liability financial

"payment of exercise price or tax liability by delivering or withholding securities"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many LLY restricted stock units did the CFO convert?

Lucas Montarce, Eli Lilly's EVP & CFO, converted 1,610 restricted stock units into 1,610 common shares on November 1, 2026; each unit represents a contingent right to receive one common share.

Why were LLY shares delivered or withheld on November 1, 2026?

678 common shares were delivered or withheld for payment of exercise price or tax liability, at a reported $1,417.54 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Montarce Lucas

(Last) (First) (Middle)

LILLY CORPORATE CENTER

(Street)

INDIANAPOLIS INDIANA 46285

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ELI LILLY & Co [ LLY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/01/2026		M		1,610	A	$0	17,868.473	D
Common Stock	11/01/2026		F		677.593	D	$1,417.54	17,190.88	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	11/01/2026		M			1,610	11/01/2026	11/01/2026	Common Stock	1,610	$0	0	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

Remarks:

	/s/ Jonathan Groff for Lucas E. Montarce, pursuant to authorization on file	11/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)